Amid COVID-19 pandemic, Gilead cuts production time for experimental drug in half By: San Francisco Business Times via Business Journals April 06, 2020 at 10:26 AM EDT The Foster City company hopes to produce 1 million course treatments for COVID-19 patients by the end of the year. Read More >>